Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.4837 USD
−3.77 M USD
89.16 K USD
5.04 M
About BioCorRx Inc.
Sector
Industry
CEO
Lourdes Felix
Website
Headquarters
Anaheim
Founded
2008
FIGI
BBG000Q351D2
BioCorRx, Inc. engages in the provision of alcoholism and opioid addiction treatment. It offers treatment philosophy that combines medical intervention and a proprietary cognitive behavioral therapy program specifically tailored for the treatment of alcoholism and other substance abuse addictions for those receiving long-term naltrexone treatments. It also engages in the research and development of sustained release naltrexone products for the treatment of addiction and other possible disorders. The company was founded by Neil Terrence Muller and George O'Neill on January 28, 2008 and is headquartered in Anaheim, CA.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of BICX is 0.3600 USD — it has increased by 4.25% in the past 24 hours. Watch BioCorRx Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange BioCorRx Inc. stocks are traded under the ticker BICX.
BICX stock has risen by 12.50% compared to the previous week, the month change is a 20.00% rise, over the last year BioCorRx Inc. has showed a −68.42% decrease.
BICX reached its all-time high on Aug 31, 2010 with the price of 95.0000 USD, and its all-time low was 0.1550 USD and was reached on Dec 23, 2020. View more price dynamics on BICX chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
BICX stock is 4.08% volatile and has beta coefficient of −0.28. Track BioCorRx Inc. stock price on the chart and check out the list of the most volatile stocks — is BioCorRx Inc. there?
Today BioCorRx Inc. has the market capitalization of 3.76 M, it has decreased by −3.03% over the last week.
Yes, you can track BioCorRx Inc. financials in yearly and quarterly reports right on TradingView.
BioCorRx Inc. is going to release the next earnings report on Nov 15, 2024. Keep track of upcoming events with our Earnings Calendar.
BICX net income for the last quarter is −1.22 M USD, while the quarter before that showed −1.24 M USD of net income which accounts for 1.57% change. Track more BioCorRx Inc. financial stats to get the full picture.
No, BICX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 15, 2024, the company has 3.00 employees. See our rating of the largest employees — is BioCorRx Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BioCorRx Inc. EBITDA is −3.94 M USD, and current EBITDA margin is −3.97 K%. See more stats in BioCorRx Inc. financial statements.
Like other stocks, BICX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BioCorRx Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BioCorRx Inc. technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BioCorRx Inc. stock shows the sell signal. See more of BioCorRx Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.